387501005: Mesalazine (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Non-opioid analgesic (substance)\Non-steroidal anti-inflammatory agent (substance)\Mesalazine
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Non-opioid analgesic (substance)\Salicylate\Mesalazine
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Gastrointestinal agent (substance)\Mesalazine

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amino acid derivative (substance)\Aminobenzoic acid derivative\Mesalazine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mesalazine	Is a	Salicylate	true	Inferred relationship	Some
Mesalazine	Is a	agent contre une maladie inflammatoire de l'intestin	false	Inferred relationship	Some
Mesalazine	Is a	Aminobenzoic acid derivative	true	Inferred relationship	Some
Mesalazine	Is a	Gastrointestinal agent (substance)	true	Inferred relationship	Some
Mesalazine	Is a	Substance with phenol structure	true	Inferred relationship	Some
Mesalazine	Is a	Non-steroidal anti-inflammatory agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
5-aminosalicylic acid poisoning	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Accidental 5-aminosalicylic acid poisoning	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Intentional 5-aminosalicylic acid poisoning	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
5-aminosalicylic acid poisoning of undetermined intent	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some	1
5-aminosalicylic acid adverse reaction (disorder)	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Mesalazine adverse reaction	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Olsalazine adverse reaction	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Sulphasalazine adverse reaction	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Allergy to mesalazine	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Mesalazine allergy	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Allergy to olsalazine	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Allergy to sulfasalazine	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
5-aminosalicylic acid overdose	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Accidental 5-aminosalicylic acid overdose	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Intentional 5-aminosalicylic acid overdose	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
5-aminosalicylic acid overdose of undetermined intent	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some	1
Mesalazine 1g/100mL retention enema	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 250 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 500 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 500mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 1g/dose rectal foam	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 2g/59mL enema	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 1g/sachet m/r granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine-containing product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mesalazine	Inferred relationship	Some	1
Mesalamine product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 66.7 mg/mL rectal suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalamine 400mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalamine 500mg/suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalamine 250mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Balsalazide disodium	Is a	False	Mesalazine	Inferred relationship	Some
Product containing mesalazine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 500mg/sachet m/r granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Accidental 5-aminosalicylic acid poisoning	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Intentional 5-aminosalicylic acid poisoning	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Allergy to mesalazine	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalamine 375mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Allergy to mesalazine	Causative agent (attribute)	True	Mesalazine	Inferred relationship	Some	1
Allergy to mesalazine	Causative agent (attribute)	False	Mesalazine	Inferred relationship	Some	3
Mesalamine 400mg gastro-resistant oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalamine 375mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalamine 250mg prolonged-release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mesalazine	Inferred relationship	Some
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Mesalazine 250 mg rectal suppository	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 250 mg rectal suppository	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 500 mg rectal suppository	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 500 mg rectal suppository	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 1 g gastro-resistant and prolonged-release oral granules sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mesalazine	Inferred relationship	Some	1
Product containing only mesalazine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine only product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each conventional release rectal suppository (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Mesalazine 66.7 mg/mL rectal suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 66.7 mg/mL rectal suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalamine therapy (procedure)	Direct substance	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1 gram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 2 gram/1 sachet prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 2 gram/1 sachet prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 4 gram/1 sachet prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 4 gram/1 sachet prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.5 gram/1 sachet prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.5 gram/1 sachet prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 3 gram/1 sachet prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 3 gram/1 sachet prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 500 milligram/1 sachet prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 500 milligram/1 sachet prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Mesalazine	Inferred relationship	Some	1
Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 500 mg gastro-resistant and prolonged-release oral granules sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 1.5 g gastro-resistant and prolonged-release oral granules sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Mesalazine 2 g gastro-resistant and prolonged-release oral granules sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 3 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 3 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 4 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 4 gram/1 sachet gastro-resistant and prolonged-release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mesalazine	Inferred relationship	Some	1
Product containing precisely mesalazine 500 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mesalazine	Inferred relationship	Some	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1481591018	Mesalamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492123018	5-ASA	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1492124012	Fisalamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2694999017	Mesalazine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3482791019	Mesalazine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3721971019	5-aminosalicylic acid	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3723085019	m-aminosalicylic acid	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
60161000195115	mesalazina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
824131000172116	mésalazine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
75581000195116	Mesalazin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module